These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23496148)

  • 21. Recent advances in transthyretin amyloidosis therapy.
    Ueda M; Ando Y
    Transl Neurodegener; 2014; 3():19. PubMed ID: 25228988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid and sensitive prenatal diagnosis of familial amyloidotic polyneuropathy ATTR Val30Met by mass spectrometry.
    Yamashita T; Ando Y; Ueda M; Okamoto S; Misumi Y; Nakamura M; Takashi O; Uchino M
    Prenat Diagn; 2009 Oct; 29(10):930-3. PubMed ID: 19609897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological features of familial amyloid polyneuropathy in endemic area.
    Kodaira M; Morita H; Shimojima Y; Ikeda S
    Amyloid; 2011 Mar; 18(1):10-8. PubMed ID: 21261557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
    Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
    Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area.
    Mazzeo A; Russo M; Di Bella G; Minutoli F; Stancanelli C; Gentile L; Baldari S; Carerj S; Toscano A; Vita G
    J Neuromuscul Dis; 2015 Jul; 2(s2):S39-S48. PubMed ID: 27858761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Swedish family with the rare Phe33Leu transthyretin mutation.
    Holmgren G; Hellman U; Jonasson J; Lundgren HE; Westermark P; Suhr OB
    Amyloid; 2005 Sep; 12(3):189-92. PubMed ID: 16194875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
    Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
    Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
    Parman Y; Adams D; Obici L; Galán L; Guergueltcheva V; Suhr OB; Coelho T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S3-S13. PubMed ID: 26734951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
    Lobato L
    J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthyretin familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Kerschen P
    Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial amyloid polyneuropathy.
    Barreiros AP; Galle PR; Otto G
    Dig Dis; 2013; 31(1):170-4. PubMed ID: 23797140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP).
    Sales-Luís Mde L; Conceição I; de Carvalho M
    Amyloid; 2003 Aug; 10 Suppl 1():26-31. PubMed ID: 14640039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
    Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
    Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR Val30Met).
    Ando Y; Ohtsu Y; Terazaki H; Kibayashi K; Nakamura M; Ando E; Matsunaga N; Obayashi K; Uchino M; Ando M; Tsunenari S
    Amyloid; 2000 Jun; 7(2):133-6. PubMed ID: 10842717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
    Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy.
    Zaros C; Genin E; Hellman U; Saporta MA; Languille L; Wadington-Cruz M; Suhr O; Misrahi M; Planté-Bordeneuve V
    Ann Hum Genet; 2008 Jul; 72(Pt 4):478-84. PubMed ID: 18460047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.